The activity of antiepileptic drugs as histone deacetylase inhibitors. - Wikidata - thesis-toulmin - TriplyDB

The activity of antiepileptic drugs as histone deacetylase inhibitors.

The activity of antiepileptic drugs as histone deacetylase inhibitors.

http://www.wikidata.org/entity/Q44961269

about

Review of pharmacological treatment in mood disorders and future directions for drug development.Overexpression of Homer1a in the basal and lateral amygdala impairs fear conditioning and induces an autism-like social impairment HDACi Valproic Acid (VPA) and Suberoylanilide Hydroxamic Acid (SAHA) Delay but Fail to Protect against Warm Hepatic Ischemia-Reperfusion Injury Regulation of Ketone Body Metabolism and the Role of PPARα The antiepileptic drug levetiracetam suppresses non-convulsive seizure activity and reduces ischemic brain damage in rats subjected to permanent middle cerebral artery occlusion Validating γ oscillations and delayed auditory responses as translational biomarkers of autism Significance of miR-196b in tumor-related epilepsy of patients with gliomas.Phase I trial of ATRA-IV and Depakote in patients with advanced solid tumor malignancies.Impact of antiepileptic drugs on thrombocytopenia in glioblastoma patients treated with standard chemoradiotherapy.HDAC5-mTORC1 Interaction in Differential Regulation of Ghrelin and Nucleobindin 2 (NUCB2)/Nesfatin-1 In vitro antineoplastic effects of brivaracetam and lacosamide on human glioma cells.Biomarker Development for Brain-Based Disorders: Recent Progress in Psychiatry Chromatin remodeling, cell proliferation and cell death in valproic acid-treated HeLa cells Topiramate in the prevention and treatment of migraine: efficacy, safety and patient preference.Preterm birth and its long-term effects: methylation to mechanisms.Abnormal emotional learning in a rat model of autism exposed to valproic acid in utero.RNA-Seq of human breast ductal carcinoma in situ models reveals aldehyde dehydrogenase isoform 5A1 as a novel potential target.Valproic acid use during radiation therapy for glioblastoma associated with improved survival.Transcriptional regulation of metabotropic glutamate receptor 2/3 expression by the NF-kappaB pathway in primary dorsal root ganglia neurons: a possible mechanism for the analgesic effect of L-acetylcarnitine Neuronal gamma-aminobutyric acid (GABA) type A receptors undergo cognate ligand chaperoning in the endoplasmic reticulum by endogenous GABA.Prolonged survival with valproic acid use in the EORTC/NCIC temozolomide trial for glioblastoma.Levetiracetam Prevents Perforin Mediated Neuronal Injury Induced by Acute Cerebral Ischemia Reperfusion.Downregulation of matrix metalloproteinases contributes to the inhibition of cell migration and invasion in HepG2 cells by sodium valproate.Safety of valproic acid in patients with chronic obstructive pulmonary disease: a population-based cohort study.Targeting the epigenome: effects of epigenetic treatment strategies on genomic stability in healthy human cells Prenatal antiepileptic exposure associates with neonatal DNA methylation differences.Valproic acid enhances the efficacy of radiation therapy by protecting normal hippocampal neurons and sensitizing malignant glioblastoma cells.Teratogenicity of antiepileptic drugs: role of drug metabolism and pharmacogenomics.The prince and the pauper. A tale of anticancer targeted agents.Brain tumors and epilepsy.Epigenetic regulation of gene expression in the inflammatory response and relevance to common diseases.Epilepsy pharmacogenetics.Seizures in low- and high-grade gliomas: current management and future outlook.Epilepsy in patients with a brain tumour: focal epilepsy requires focused treatment.The strategy for enhancing temozolomide against malignant glioma.Levetiracetam compared with valproic acid for the prevention of postoperative seizures after supratentorial tumor surgery: a retrospective chart review.Valproic acid: a new candidate of therapeutic application for the acute central nervous system injuries.Treatment of epileptic seizures in brain tumors: a critical review.Antiepileptic drugs in patients with malignant brain tumor: beyond seizures and pharmacokinetics.Repurposing some older drugs that cross the blood-brain barrier and have potential anticancer activity to provide new treatment options for glioblastoma.

P2860

Q26853509-124A7ABE-54C5-4C83-B4BB-59FF1583ADDA Q27322939-F640B8CE-87E6-4BE3-9970-C91BF3FD03D4 Q27327201-921AF869-986D-4500-B9DE-CA6C16C9803D Q28073224-8F7C6C23-D0E7-4BA3-BA75-185A90C96245 Q28535091-33544B41-EE97-43CC-BD30-900C7B9B5A03 Q30372103-4C8397A7-2801-4CCA-AEFF-8A384C63BDFB Q31104534-D3DDE2BD-0988-4C8D-A40C-F7D40371379B Q33388447-FD339307-9B4F-4B36-8481-6EBF505FEEDF Q33400189-A79C2296-3089-4BF0-9512-A6AACAF93415 Q33631521-40EE6CD0-3F17-4EB1-A582-90DAFBB8D421 Q33768138-26691221-2E85-4C1E-AD94-AEA31D6C04B0 Q34010400-D8ACF360-5932-4B87-99B3-F38ED3BF1F7B Q34113695-CC64359A-2A6D-4236-A68E-2FBCE40BAC41 Q34180705-421293E6-7852-4E19-80AB-DEC063A4C6CA Q34317992-B27661E6-1E83-451F-8BC0-88A5E7D41003 Q34495960-8E987AA5-754D-4A41-9B7F-87B057DB5C2D Q34510318-A3605A21-5573-4D38-A041-4DEBD33A4DBC Q34633117-49FE042D-57EA-441C-B50E-1A84EE1264FA Q34997110-F0B81761-C9EA-486B-9102-AEFA4A5EF39C Q35617513-DD93736E-D3BC-478F-B6F2-2A867FDB658E Q35691532-3E2DBFA2-5769-4204-86B4-1788040F086E Q35802649-B8E7AA8F-ECDA-4527-BE0C-0E4444C05797 Q35804013-7942486A-E487-4905-ADEC-D50C96287614 Q35835849-9AFABB92-44BB-4524-9D2F-518453EA2D98 Q36001852-62EEDA9F-3512-419E-A689-D68D2B5DBD85 Q36012665-CD8B2BBB-9258-44E2-920B-85C6882F77E9 Q36544286-B4A2EE9A-30D2-4ABA-B002-EC23F8C5BC34 Q36857493-BF70C04E-DB85-4D39-88B3-BF14384E4E6D Q37042365-CA55C8D3-2FDE-43F7-91B3-345E90B1C0A3 Q37174060-C95E5361-7D52-4960-A103-0435555E16D0 Q37232600-4266260C-F54A-4F5D-B6AE-15D18F129D98 Q37486720-6D246876-10F1-41A2-958E-82CE9621E3D1 Q37752365-EA413716-4839-4F32-B376-76C5956332B7 Q37968607-406B63F4-F7A6-4EB3-82AA-224BE939A3FA Q38036657-B696E017-31DB-48E3-BCE4-61AD9798A06D Q38127128-6C7FA334-1997-44AB-9E24-348FC96E8A99 Q38183768-2112D7A5-AC35-4A04-AAB4-1247922BD533 Q38206723-DF79E349-6CD2-4D82-B5DC-85C7C16943B7 Q38495389-13C10810-E2DB-4BC4-BE96-46BC37E47D6E Q38587724-551C175D-EC2E-436A-AB30-C50DE6852A67

P2860

The activity of antiepileptic drugs as histone deacetylase inhibitors.

http://www.wikidata.org/entity/Q44961269

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh

2004年學術文章

@zh-hant

name

The activity of antiepileptic drugs as histone deacetylase inhibitors.

@en

The activity of antiepileptic drugs as histone deacetylase inhibitors.

@nl

type

label

The activity of antiepileptic drugs as histone deacetylase inhibitors.

@en

The activity of antiepileptic drugs as histone deacetylase inhibitors.

@nl

prefLabel

The activity of antiepileptic drugs as histone deacetylase inhibitors.

@en

The activity of antiepileptic drugs as histone deacetylase inhibitors.

@nl

P1433

Q44961269-CF65C870-817A-45BA-B2BE-07D087776768

P1476

Q44961269-42277B7C-7029-448C-BA5A-755ECC5A8657

P2093

Q44961269-1061DB79-E9A6-4E99-B090-2A449FDD5099

Q44961269-3593F38C-6DD6-4550-8684-32AF95088E0A

Q44961269-BDC9BEA2-7185-4E9D-9975-7EB8228232C4

Q44961269-C03DE52E-B8CB-4990-8E58-2A27EBEBAEB0

Q44961269-DA3E561A-AC3E-4547-9122-098C5D396AED

P2860

Q44961269-027AA72E-EC3E-4BA9-8B23-8481FFB9ACFC

Q44961269-0FF522BA-89F5-4AC6-8B78-ABE0E293F2C9

Q44961269-1468615C-D8F5-4E3B-98C9-0B68B5FCE829

Q44961269-21B2A439-CAAD-4EE5-8F8E-67A65122A559

Q44961269-24B14B58-E068-4159-8905-A0B6415E9AE8

Q44961269-2BE3A678-8697-4E42-ABA5-1272ECBF0D9F

Q44961269-2C0E7F08-BD0B-4FFE-B3A1-ACE9FA487962

Q44961269-4244CDE4-E64F-4C3A-9512-198224972B6F

Q44961269-52D9166E-1B9A-4AAD-B3D1-FD78B355E411

Q44961269-6AD4C485-30CE-4335-9D18-4945DBFC6245

P304

Q44961269-F5FCD76F-EF26-4FF7-9002-2F833AC39D13

P31

Q44961269-20524122-5739-408B-A13C-66DA9D380B04

P356

Q44961269-35F5C9FE-58B4-4FC0-BCFB-4B2699937257

P433

Q44961269-0CC52844-CC9D-41F0-AE79-51D6F081C5B5

P478

Q44961269-A556A093-474A-4B6C-8DFB-AEACF91B979F

P50

Q44961269-D8F6C7B5-D391-4080-B672-FEDDF5CF6D29

P577

Q44961269-A60EDCA7-98E9-4976-862F-14F67EE1C062

P5875

Q44961269-C5574466-F63B-4FB1-9E45-8ED6F36234EE

P698

Q44961269-1149A004-B66D-493A-BCC7-7ABD49A67A53

P356

J.0013-9580.2004.00104.X

P1433

P1476

The activity of antiepileptic drugs as histone deacetylase inhibitors.

@en

P2093

Boris Yagen

http://www.w3.org/2001/XMLSchema#string

Eyal Sobol

http://www.w3.org/2001/XMLSchema#string

Meir Bialer

http://www.w3.org/2001/XMLSchema#string

Miriam Shmuel

http://www.w3.org/2001/XMLSchema#string

Yoram Altschuler

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of HDAC10, a novel class II human histone deacetylase containing a leucine-rich domain

A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression.

Histone deacetylases (HDACs): characterization of the classical HDAC family

An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability.

A role for histone deacetylase activity in HDAC1-mediated transcriptional repression

Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors

Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells

Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen

Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila

Cloning and characterization of a novel human histone deacetylase, HDAC8

P304

737-744

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.0013-9580.2004.00104.X

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

45

http://www.w3.org/2001/XMLSchema#string

P50

P577

2004-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8477433

http://www.w3.org/2001/XMLSchema#string

P698

15230695

http://www.w3.org/2001/XMLSchema#string